- Home
- NMG vs BIOA Comparison
NMG vs BIOA Comparison
Compare NMG & BIOA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | NMG | BIOA |
|---|---|---|
| Founded | 2011 | 2015 |
| Country | Canada | United States |
| Employees | N/A | 62 |
| Industry | Other Metals and Minerals | Biotechnology: Pharmaceutical Preparations |
| Sector | Basic Materials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 671.4M | 757.0M |
| IPO Year | 2015 | N/A |
Fundamental Metrics
Financial Performance| Metric | NMG | BIOA |
|---|---|---|
| Price | $1.91 | $17.49 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 2 | 6 |
| Target Price | $5.75 | ★ $51.50 |
| AVG Volume (30 Days) | ★ 946.2K | 356.6K |
| Earning Date | 05-13-2026 | 05-07-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | $720.93 |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $1.60 | $3.79 |
| 52 Week High | $6.06 | $24.00 |
Technical Indicators
Market Signals| Indicator | NMG | BIOA |
|---|---|---|
| Relative Strength Index (RSI) | 40.72 | 47.90 |
| Support Level | $1.81 | $15.74 |
| Resistance Level | $2.00 | $18.65 |
| Average True Range (ATR) | 0.11 | 1.06 |
| MACD | -0.02 | 0.13 |
| Stochastic Oscillator | 25.56 | 45.03 |
Price Performance
Historical ComparisonAbout NMG Nouveau Monde Graphite Inc.
Nouveau Monde Graphite Inc is a mineral exploration company. The company specializes in the exploration, evaluation, and development of mineral properties located in Quebec and is developing a natural graphite-based anode material that would qualify as battery-grade material to supply the lithium-ion industry. The Company currently operates in two segments: the Mining projects (which includes the Matawinie Mine project and the Uatnan Mining Project) and the Battery Material Plant project.
About BIOA BioAge Labs Inc.
Bioage Labs Inc is a clinical-stage biopharmaceutical company developing therapeutic product candidates for metabolic diseases by targeting the biology of human aging. The company's technology platform and differentiated human datasets enable the identification of targets based on insights into molecular changes that drive aging. The Company operates and manages its business as one reportable and operating segment, which is the business of extending healthy human life by targeting molecular causes of aging.